UBS Bloomberg Commodity CMCI SF UCITS ETF (USD) A-acc USD is a commodities ETF from UBS tracking the Bloomberg Commodity CMCI SF index through physical replication. Domiciled in Ireland and launched in 2017, the fund manages about 765 M € and charges a TER of 0.30% — 30 € per year on a €10,000 investment. Income is automatically reinvested in the fund (accumulating).
UBS Bloomberg Commodity CMCI SF UCITS ETF (USD) A-acc USD competes with 3 other products on the same index (Bloomberg Commodity CMCI SF): it ranks 1st by fund size and 1st by ongoing cost, with a TER of 0.30% against a group median of 0.30%. It has been listed since 2017, 9 years of track record — the oldest in its comparison group.
On a €10,000 investment the TER costs 30 € a year, and no product in the group costs less.
Replication is physical: the fund holds the underlying securities directly. The ten largest positions account for 543.3% of the portfolio.
Income is accumulated: no distribution is paid out, the share price absorbs it. In a savings plan this removes the need to reinvest dividends by hand. The fund is denominated in USD. That is not the same as currency risk: the exposure comes from the currencies of the underlying holdings, not from the denomination or the trading currency of a given listing.
The fund is domiciled in Ireland, which determines the tax treatment of income received by the fund and the supervisory authority.
| Métropole Télévision S.A. | 396.1% |
| Apple Inc. | 24.4% |
| NVIDIA Corporation | 23.3% |
| Microsoft Corporation | 21.3% |
| Alphabet Inc Class A | 18.6% |
| Tesla Inc | 16.5% |
| Intesa Sanpaolo SpA | 15.8% |
| Amazon.com Inc | 15.3% |
| Enel SpA | 12.0% |
| XETRA | BCFU | USD |
| London Stock Exchange | UD07 | GBP |
| London Stock Exchange | BCCU | USD |
| SIX Swiss Exchange | BCCMA | USD |
Source: the fund's KID and the issuer's official documentation — data verified as of July 2026.
This page is informational and is not an investment recommendation. Figures may contain errors or be out of date: always check the KID and the issuer's factsheet before any decision.